ALXO · ISSUER CIK 1810182
ALX ONCOLOGY HOLDINGS INC
Between Aug 1, 2026 and Oct 29, 2026, 2 ALX ONCOLOGY HOLDINGS INC insiders reported $0.00 of open-market purchases and $5K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$5KInsider selling
−$5KNet open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202617:51 | Aug 17, 2026 | ALXO | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $1.93 | −2,230 | 294,379 | -1% | −$4K | ||
| Aug 18, 202617:50 | Aug 17, 2026 | ALXO | SVP, FINANCE AND CAO | S · Sell | $1.93 | −573 | 87,828 | -1% | −$1K |